Speaker:              Dr. Roshan Nimje
                      Biocon Bristol Myers Squibb Research Centre (BBRC),
                      Bangalore, India.

Title:                “Development of a Stereoselective and Scalable
                      Synthesis for the Potent Indoleamine 2,3-dioxygenase 1
                      (IDO1) Inhibitor, BMT-297376; N-((R)-1-((cis)-4-(3-
                      (difluoromethyl)-2-methoxypyridin-4-
                      yl)cyclohexyl)propyl)-6-methoxynicotinamide”

Day and Date:         Friday, September 23, 2022

Time:                 4.00 pm.

Venue:                Room no. 350, Chemistry Department
                      Second floor, Annex